Spire Wealth Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8
| Closed | -$872 | – | 2370 |
|
|
2023
Q2 | $872 | Hold |
8
| – | – | ﹤0.01% | 2324 |
|
|
2023
Q1 | $2.44K | Hold |
8
| – | – | ﹤0.01% | 2220 |
|
|
2022
Q4 | $3K | Hold |
8
| – | – | ﹤0.01% | 1946 |
|
|
2022
Q3 | $2K | Hold |
8
| – | – | ﹤0.01% | 1926 |
|
|
2022
Q2 | $2K | Hold |
8
| – | – | ﹤0.01% | 2331 |
|
|
2022
Q1 | $3K | Hold |
8
| – | – | ﹤0.01% | 2317 |
|
|
2021
Q4 | $3K | Hold |
8
| – | – | ﹤0.01% | 2680 |
|
|
2021
Q3 | $4K | Hold |
8
| – | – | ﹤0.01% | 2319 |
|
|
2021
Q2 | $4K | Buy |
+8
| New | +$4K | ﹤0.01% | 2346 |
|